Guggenheim Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-60,711
| Closed | -$3.25M | – | 3042 |
|
|
2016
Q1 | $3.25M | Sell |
60,711
-15,604
| -20% | -$834K | 0.01% | 1247 |
|
|
2015
Q4 | $8.62M | Sell |
76,315
-11,430
| -13% | -$1.29M | 0.03% | 798 |
|
|
2015
Q3 | $10.3M | Sell |
87,745
-33,851
| -28% | -$3.98M | 0.03% | 730 |
|
|
2015
Q2 | $9.42M | Buy |
121,596
+3,604
| +3% | +$279K | 0.02% | 861 |
|
|
2015
Q1 | $6.83M | Sell |
117,992
-2,953
| -2% | -$171K | 0.02% | 1017 |
|
|
2014
Q4 | $3.9M | Buy |
+120,945
| New | +$3.9M | 0.01% | 1263 |
|
|
2014
Q1 | – | Sell |
-13,009
| Closed | -$219K | – | 3365 |
|
|
2013
Q4 | $219K | Sell |
13,009
-306
| -2% | -$5.15K | ﹤0.01% | 2745 |
|
|
2013
Q3 | $141K | Buy |
13,315
+1,498
| +13% | +$15.9K | ﹤0.01% | 2736 |
|
|
2013
Q2 | $66K | Buy |
+11,817
| New | +$66K | ﹤0.01% | 2795 |
|